Skip to content

ATHE - ALTERITY THERAPEUTICS LTD - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Alterity Therapeutics Ltd

ATHE · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ATHEAlterity Therapeutics Ltd

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $5.89
52-wk low: $2.66
Prev close: $4.43
Mkt cap: $87.0M
Beta: -0.04
P/S: 13.1x

Smart money

1 fund holds a position.

Real smart money

Funds holding this stock

1 holder

Combined position$202K

CI
Citadel
Ken Griffin · Q2 2026 13F
$202K
position

Coverage gaps for ATHE

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -219.9%
Market cap: $87M

Valuation

P/S13.11
P/B2.15

Quality

Operating margin-372.6%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ATHE
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $87.00M
Beta: -0.04

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.2x

Profit margin

-219.9%

Op margin

-372.6%

ROE

-47.0%

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

Reports Aug 27, 2026, in 6 days

-47.0%

ROA-32.5%

Growth

Beta-0.04